This dual action may make Mounjaro more effective for weight management and blood glucose control than other GLP-1 medications that target only one receptor, like Ozempic and Wegovy (both manufactured by Novo Nordisk) which contain the active ingredient, semaglutide
Larger, longer-term randomized trials examining GLP-1 effects on aging in diverse populations including healthy adults without metabolic disease will be needed before any anti-aging indication could realistically reach the FDA's approval process
Granger CV, Dewis LS, Peters NC, Sherwood CC, Barrett JE
Participants should notify their study team before starting any new supplement and report any adverse effects in accordance with the trial protocol
And it signals satiety centers in the brain, telling you that you are full
At Infusion IV Lounge Denver, the Myers Cocktail is one of our signature offerings